Related Experiment Video

Updated: Jun 5, 2026

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
09:52

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Published on: December 28, 2017

MicroRNA-related cofilin abnormality in Alzheimer's disease

Jiaqi Yao1, Tom Hennessey, Alex Flynt

  • 1Department of Neurology, Weill-Cornell Medical College, New York, New York, United States of America.

Plos One
|December 24, 2010
PubMed

Insights

MicroRNAs 103 and 107 regulate cofilin, a protein involved in actin rod formation. Reduced microRNA levels in Alzheimer's disease models correlate with increased cofilin and pathological structures.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Actin and cofilin form rod-like structures in Alzheimer's disease (AD) brains.
  • The mechanisms and pathological role of these actin-cofilin rods remain unclear.

Purpose of the Study:

  • Investigate the role of microRNAs in the formation of actin-cofilin rods in Alzheimer's disease.
  • Identify specific microRNAs that regulate cofilin expression.

Main Methods:

  • Utilized a transgenic mouse model of Alzheimer's disease.
  • Measured levels of cofilin protein and specific microRNAs (miR-103, miR-107).
  • Assessed the formation of actin-cofilin rod-like structures.

Main Results:

  • MicroRNAs 103 and 107 were identified as repressors of cofilin translation.
  • Reduced levels of miR-103 or miR-107 were associated with increased cofilin protein.
  • Lower microRNA levels correlated with the formation of rod-like structures in the AD mouse model.

Conclusions:

  • MicroRNAs, specifically miR-103 and miR-107, play a significant role in regulating cofilin.
  • Dysregulation of these microRNAs may contribute to cytoskeletal pathology in Alzheimer's disease.
  • Targeting microRNA pathways could offer a novel therapeutic strategy for AD.

More Related Videos

Electrocorticographic Recording of Cerebral Cortex Areas Manipulated Using an Adeno-Associated Virus Targeting Cofilin in Mice08:44

Electrocorticographic Recording of Cerebral Cortex Areas Manipulated Using an Adeno-Associated Virus Targeting Cofilin in Mice

Published on: February 21, 2021

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...